Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen

Japan's Eisai (4523.T) said on Monday its Alzheimer's treatment developed with Biogen (BIIB.O), Leqembi, was approved by the country's health ministry, making it the second nation after the United States to clear its use.